Open AccessAbstract 957: Use of angiotensin system inhibitors is associated with longer overall survival in pancreatic ductal adenocarcinoma patients who underwent pancreatectomy
Author(s) -
Hao Líu,
Matthias Pinter,
João Incio,
Hang Lee,
William W. Ho,
Jonathan A. Crain,
Kamila Naxerova,
Mengyang Di,
A. Jacobson,
Daniella Dias Santos,
Andrea Zanconato,
Vikram Deshpande,
Keith D. Lillemoe,
Carlos Fernandez del Castillos,
Michael Downes,
Ronald M. Evans,
James Michaelson,
Cristina R. Ferrone,
Yves Boucher,
Jain K. Rakesh
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-957
Subject(s) - medicine , proportional hazards model , pancreatic ductal adenocarcinoma , retrospective cohort study , univariate analysis , oncology , adenocarcinoma , multivariate analysis , pancreatic cancer , angiotensin receptor , angiotensin receptor blockers , cancer , survival analysis , angiotensin ii , gastroenterology , angiotensin converting enzyme , receptor , blood pressure